Skaff Michael C's Form 4 filing
Vivos Therapeutics, Inc. (VVOS) · filed Apr 2, 2026
- Accession no.
- 0002074003-26-000008
- Filed
- Apr 2, 2026, 7:34 PM ET
- Trade date
- Mar 31, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market purchases total $1.81M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Skaff Michael CCIK 0002074003 | 10% Owner |
| V-Co Investors 3 LLCCIK 0002114460 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | PPurchaseAcquired | +1,044,777 | $1.34 | +$1,400,001.18 | 1,044,777 | Indirect | |
| Mar 31, 2026 | Common Stock | PPurchaseAcquired | +308,848 | $1.34 | +$413,856.32 | 1,353,625 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | PPurchaseAcquired | +429,957 | $1.34 | +$576,142.38 | 429,957 | Indirect | |
| Mar 31, 2026 | Common Stock | PPurchaseAcquired | +1,783,582 | $1.34 | +$2,389,999.88 | 1,783,582 | Indirect | |
| Mar 31, 2026 | Common Stock | PPurchaseAcquired | +1,783,582 | $1.34 | +$2,389,999.88 | 1,783,582 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.